Log In
Print this Print this

TRV 101

  Manage Alerts
Collapse Summary General Information
Company Treventis Corp.
DescriptionBrain-penetrant small molecule that binds to beta amyloid and microtubule-associated protein tau (MAPT; tau; FTDP-17)
Molecular Target Beta amyloid ; Microtubule-associated protein tau (tau) (MAPT) (FTDP-17)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today